NCT04717375 2025-08-07Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid TumorsSanofiPhase 1/2 Terminated125 enrolled
NCT00733031 2010-12-10Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918AstraZenecaPhase 1 Terminated75 enrolled